Efficacy and Safety of Crisaborole Ointment, 2%, for the Treatment of Mild-to-Moderate Atopic Dermatitis Across Racial and Ethnic Groups-Reference-Cited by-同舟云学术

Efficacy and Safety of Crisaborole Ointment, 2%, for the Treatment of Mild-to-Moderate Atopic Dermatitis Across Racial and Ethnic Groups

Published:2019-07-01 Issue:5 Volume:20 Page:711-723
ISSN:1175-0561
Container-title:American Journal of Clinical Dermatology
language:en
Short-container-title:Am J Clin Dermatol

Author:

Callender Valerie D.^ORCID,Alexis Andrew F.,Stein Gold Linda F.,Lebwohl Mark G.,Paller Amy S.,Desai Seemal R.,Tan Huaming,Ports William C.,Zielinski Michael A.,Tallman Anna M.

Funder

Pfizer Inc.

Publisher

Springer Science and Business Media LLC

Subject

Dermatology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s40257-019-00450-w.pdf

Reference29 articles.

1. Bieber T. Atopic dermatitis. N Engl J Med. 2008;358(14):1483–94.

2. Bieber T. Atopic dermatitis. Ann Dermatol. 2010;22(2):125–37.

3. Schachner L, Ling NS, Press S. A statistical analysis of a pediatric dermatology clinic. Pediatr Dermatol. 1983;1(2):157–64.

4. Shaw TE, Currie GP, Koudelka CW, Simpson EL. Eczema prevalence in the United States: data from the 2003 National Survey of Children’s Health. J Investig Dermatol. 2011;131(1):67–73.

5. Horii KA, Simon SD, Liu DY, Sharma V. Atopic dermatitis in children in the United States, 1997–2004: visit trends, patient and provider characteristics, and prescribing patterns. Pediatrics. 2007;120(3):e527–34.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revisiting immunotherapeutic strategies for the management of atopic dermatitis;Exploration of Asthma & Allergy;2024-08-09

2. Efficacy and safety of crisaborole ointment, 2%, in participants aged ≥45 years with stasis dermatitis: Results from a fully decentralized, randomized, proof-of-concept phase 2a study;Journal of the American Academy of Dermatology;2024-05

3. Efficacy and Safety of Crisaborole Ointment 2% in Chinese Patients Aged ≥ 2 Years with Mild to Moderate Atopic Dermatitis;Dermatology and Therapy;2024-05

4. Topical Treatments in Atopic Dermatitis: An Expansive Review;Journal of Clinical Medicine;2024-04-10

5. Special Considerations of Atopic Dermatitis in Skin of Color;Advances in Experimental Medicine and Biology;2024